| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5957066 | Chest | 2011 | 8 Pages |
Abstract
In a population of patients with AF revascularized with stents, even those with CHADS2 ⤠1 should be regarded as being at high risk. OAC should be considered as thromboprophylaxis in patients with AF revascularized with coronary stents.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Juan M. MD, PhD, Francisco MD, PhD, Sergio MD, José MD, PhD, José A. MD, Vanessa MD, PhD, Javier MD, PhD, Eduardo MD, PhD, Francisco MD, PhD, Mariano MD, PhD, Gregory Y.H. MD,